Induction of ovulation and risk of breast cancer: An overview and perspectives

Gynecological Endocrinology

Volumn 11, Issue 5, 1997, Pages 357-364

  Brzezinski, A ^a   Schenker, J G ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Breast cancer; Estrogen; Human chorionic gonadotropin; Ovulation induction; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE; ESTROGEN; FERTILITY PROMOTING AGENT; GONADORELIN AGONIST; PROGESTERONE; TAMOXIFEN;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER RISK; FEMALE; FEMALE INFERTILITY; HUMAN; OVULATION INDUCTION; PRIORITY JOURNAL; REVIEW;

EID: 0030731633     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599709152560     Document Type: Review

References (42)

1. National Cancer Institute (1989). Annual Cancer Statistics Review, Including Cancer Trends; 1950-1985. (Bethesda, Maryland: National Institute of Health, USA)
2. Paffenbarger, R. S., Kampert, J. B. and Chang, H. (1980). Characteristics that predict breast cancer before and after the menopause. Am. J. Epidemiol., 112, 258-62
3. Vessey, M., Baron, J., Doll, M., McPherson, K. and Yeast, D. (1983). Oral contraceptives and breast cancer: final report of an epidemiological study. Br. J. Cancer, 47, 455-60
4. Brzezinski, A. and Schenker, J. G. (1982). Review: Oral contraceptives and menopausal estrogens in relation to breast neoplasia. Isr. J. Med. Sci., 18, 433-8
5. Mcgonigle, K. F. and Huggins, G. R. (1992). Oral contraceptives and breast disease. Fertil. Steril., 56, 799-819
6. Kelsey, J. L. (1993). Reproductive factors and breast cancer. Epidemiol. Rev., 15, 36-47
7. Fishel, S. and Jackson, P. (1989). Follicular stimulation for high tech pregnancies: are we playing it safe? Br Med. J., 299, 309-11
8. Dietl, J. (1991). Ovulation and ovarian cancer. Lancet, 338, 445
9. Whittemore, A. S. (1994). The risk of ovarian cancer after treatment for infertility (Editorial). N. Engl. J. Med., 331, 805-6
10. Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E. and Self, S. G. (1994). Ovarian tumors in a cohort of infertile women. N. Engl. J. Med., 331, 771-6
11. Ron, E., Lunenfeld, B., Menczer, J., Blumstein, T., Katz, L., Oelsner, G. and Serr, D. (1987). Cancer incidence in a cohort of infertile women. Am. J. Epidemiol, 125, 780-90
12. Brinton, L. A., Hoover, R. and Fraumeni, J. F. Jr. (1983). Reproductive factors in the aetiology of breast cancer. Br. J. Cancer, 47, 757-62
13. Coulam, C. B., Annegers, J. F. and Kranz, J. S. (1983). Chronic anovulation syndrome and associated neoplasia. Obstet. Gynecol., 61, 403-7
14. Gammon, M. D. and Thompson, W. D. (1990). Infertility and breast cancer: a population-based case-control study. Am. J. Epidemiol., 132, 708-16
15. Cowan, L. D., Gordis, L. and Tonasica, J. A. (1981). Breast cancer incidence in women with a history of progesterone deficiency. Am. J. Epidemiol., 114, 209-17
16. Sellers, T. A, Kushi, L. H., Potter, J. D., Kaye, S. A., Nelson, C. L., McGovern, P. G. and Folsom, A. R. (1992). Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N. Engl. J. Med., 326, 1323-9
17. Sellers, T. A., Potter, J. D., Severson, R. K., Bostick, R. M., Nelson, C. L., Kushi, L. H. and Folsom, A. R. (1993). Difficulty becoming pregnant and family history as interactive risk factors for postmenopausal breast cancer: the Iowa Women's Health Study. Cancer Causes Control, 4, 21-8
18. Folsom, A., Sellers, T. and Kaye, S. (1993). Infertility linked to breast cancer (Letter). Br. Med., J., 306, 1065
19. Moseson, M., Koenig, K. L., Shore, R. E. and Pasternack, B. S. (1993). The influence of medical conditions associated with hormones on the risk of breast cancer. Int. J. Epidemiol., 22, 1000-9
20. Meirow, D., Laufer, N. and Schenker, J. G. (1992). Ovulation induction in in vitro fertilization. Gynecol. Endocrinol., 6, 211-24
21. Boring, C. C., Squires, R. S. and Tong, T. (1991). Cancer statistics. CA, 41, 19-24
22. Podhajcer, O. L., Bravo, A. I., Dain, L., Guman, N., Bover, L. and Mordoh, J. (1988). In vitro analysis of the cellular proliferative response to 17-β-estradiol of human breast cancer. Cancer, 61, 1807-12
23. MacMahon, B. and Austin, J. H. (1969). Association of carcinoma of the breast and corpus uteri. Cancer, 23, 275-81
24. Trichopoulos, D., MacMahon, B. and Cole, P. (1972). Menopause and breast cancer risk. J. Natl. Cancer Inst., 48, 605-13
25. Symmers, W. S. C. (1968). Carcinoma of the breast in transsexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. Br. Med. J., 1, 83-7
26. Schlesselman, J. J. (1990). Oral contraceptives and breast cancer. Am. J. Obstet. Gynecol., 163, 1379-87
27. Colditz, G. A. (1996). Postmenopausal estrogens and breast cancer. J. Soc. Gynecol. Investig., 3, 50-6
28. Badwe, R. A., Gregory, W. M., Caudary, M. A., Richards, M. A., Bently, A. E., Rubens, R. D. and Fentiman, S. I. (1991). Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet, 337, 1261-6
29. Korenman, S. G. (1980). Oestrogen window hypothesis for the etiology of breast cancer. Lancet, i, 700-1
30. Adami, H. O., Persson, I., Hoover, R., Schairer, C. and Bergkvist, L. (1989). Risk of cancer in women receiving hormone replacement therapy. Int. J. Cancer, 44, 833-9
31. Staffa, J. A., Newschaffer, C. J., Jones, J. K. and Miller, V. (1992). Progestins and breast cancer: an epidemiologic review. Fertil. Steril., 57, 473-91
32. Potten, C. S., Watson, R. J., Williams, G. T., Tickle, S., Roberts, S. A., Harris, M. and Howell, A. (1988). The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br. J. Cancer, 58, 163-70
33. Anderson, T. J., Battersby, S., King, R. J. B., McPherson, K. and Going, J. J. (1989). Oral contraceptive use influences resting breast proliferation. Hum. Pathol., 20, 1137-43
34. Henderson, B. E., Pike, M. C. and Casagrande, J. T. (1981). Breast cancer and the estrogen window hypothesis. Lancet, 2, 363-4
35. Bernstein, L., Hanisch, R., Sullivan-Halley, J. and Ross, R. K. (1995). Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol. Biom. Prev., 4, 437-40
36. Vici, P., Veltri, E., Carpano, S., Di-Lauro, L. and Lopez, M. (1991). Buserelin therapy in postmenopausal patients with advanced carcinoma. Clin. Ther., 136, 195-9
37. Kakar, S. S., Grizzle, W. E. and Neill, J. D. (1994). The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Mol. Cell Endocrinol., 106, 145-9
38. Brzezinski, A., Peretz, T., Mor-Yosef, S. and Schenker, J. G. (1994). Ovarian stimulation and breast cancer: is there a link? Cynecol. Oncol., 52, 292-5
39. Israel Cancer Registry (1992). Cancer in Israel: Facts and Figures 1982-1986. (Israel: Ministry of Health)
40. Venn, A., Watson, L., Lumley, J., Giles, G., King, C. and Healy, D. (1995). Breast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet, 346, 995-1000
41. Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E. and Self, S. G. (1996). Risk of breast cancer in a cohort of infertile women. Gynecol. Oncol., 60, 3-7
42. Braga, C., Negri, E., La Vacchio, C., Rarazzini, F., Del Masso, L. and Franceschi, S. (1996). Fertility treatment and risk of breast cancer. Hum. Reprod., 11, 300-3